MRDC FAMILY

DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Contact Us | Site Map

Transforming Healthcare through Innovative and Impactful Research

Synopsis of Open Program Funding Opportunities

Melanoma
Traumatic Brain Injury and Psychological Health

FY21 Melanoma Research Program (MRP)

Mechanism	Program Announcement/Instructions	Release Date	Funding Amount	Submission Deadline
Discovery Award (DA)	Program Announcement Application Instructions	August 18, 2021	The maximum allowable funding for the entire period of performance is $200,000 for direct costs. Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement. The maximum period of performance is 2 years.	Pre-Application (Letter of Intent): October 20, 2021 Application: November 10, 2021

FY21 Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP)

Mechanism	Program Announcement/Instructions	Release Date	Funding Amount	Submission Deadline
Clinical Trial Award (CTA)	Targeted Broad Agency Announcement Submission Instructions	August 6, 2021	Funding Level 1: The maximum allowable funding for the entire period of performance is $750,000 for *total* costs. Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement. The maximum period of performance is 3 years. Funding Level 2: The maximum allowable funding for the entire period of performance is $3 million (M) for *total* costs. Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement. The maximum period of performance is 4 years. Funding Level 3: The maximum allowable funding for the entire period of performance is $6M for *total* costs. Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement. The maximum period of performance is 4 years.	Pre-Application (Preproposal): November 1, 2021 Application: December 16, 2021
Focused Program Award (FPA)	Targeted Broad Agency Announcement Submission Instructions	August 6, 2021	The maximum allowable funding for the entire period of performance is $8M for *total* costs. Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement. The maximum period of performance is 4 years.	Pre-Application (Preproposal): November 1, 2021 Application: December 16, 2021
Translational Research Award (TRA)	Program Announcement Application Instructions	August 6, 2021	The maximum allowable funding for the entire period of performance is $1.5M for *total* costs. Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement. The maximum period of performance is 3 years.	Pre-Application (Preproposal): November 1, 2021 Application: December 16, 2021